Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA discourages inclusion of OTC drugs in California VOC regulation.

This article was originally published in The Tan Sheet

Executive Summary

CTFA OBJECTS TO CALIFORNIA PROPOSAL TO ESTABLISH VOC REGS FOR OTCs and prescription drugs intended for external use. In comments filed with the California Air Resources Board (CARB) on June 19, the Cosmetic Toiletry and Fragrance Association argued that OTCs should not be subject to California's volatile organic compound (VOC) regulations because over-the-counter drugs "are even more heavily regulated" by FDA than are personal care products.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel